These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34932720)

  • 21. Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults.
    Borie R; Kannengiesser C; Dupin C; Debray MP; Cazes A; Crestani B
    Presse Med; 2020 Jun; 49(2):104024. PubMed ID: 32437840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Idiopathic pulmonary fibrosis and non-specific interstitial pneumonia].
    Suga M
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1030-5. PubMed ID: 16846051
    [No Abstract]   [Full Text] [Related]  

  • 23. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
    Mackintosh JA; Chambers DC
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237995
    [No Abstract]   [Full Text] [Related]  

  • 24. Classification and recent advances in idiopathic interstitial pneumonia.
    Nagai S; Kitaichi M; Izumi T
    Curr Opin Pulm Med; 1998 Sep; 4(5):256-60. PubMed ID: 10813199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.
    Juge PA; Borie R; Kannengiesser C; Gazal S; Revy P; Wemeau-Stervinou L; Debray MP; Ottaviani S; Marchand-Adam S; Nathan N; Thabut G; Richez C; Nunes H; Callebaut I; Justet A; Leulliot N; Bonnefond A; Salgado D; Richette P; Desvignes JP; Lioté H; Froguel P; Allanore Y; Sand O; Dromer C; Flipo RM; Clément A; Béroud C; Sibilia J; Coustet B; Cottin V; Boissier MC; Wallaert B; Schaeverbeke T; Dastot le Moal F; Frazier A; Ménard C; Soubrier M; Saidenberg N; Valeyre D; Amselem S; ; Boileau C; Crestani B; Dieudé P
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28495692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive dyspnoea in a 40-yr-old female.
    Ghekiere O; Weynand B; Collard P; Coche E
    Eur Respir J; 2003 Apr; 21(4):728-31. PubMed ID: 12762364
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cyclosporin and diffuse alveolar interstitial lung disease].
    Losa García JE; Mateos Rodríguez F; Jiménez López A; Pérez Arellano JL
    Arch Bronconeumol; 1996; 32(6):302-6. PubMed ID: 8814824
    [No Abstract]   [Full Text] [Related]  

  • 28. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial pneumonia induced by bleomycin treatment is exacerbated in Angptl2-deficient mice.
    Motokawa I; Endo M; Terada K; Horiguchi H; Miyata K; Kadomatsu T; Morinaga J; Sugizaki T; Ito T; Araki K; Morioka MS; Manabe I; Samukawa T; Watanabe M; Inoue H; Oike Y
    Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L704-L713. PubMed ID: 27542805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status of the prevention and treatment of intersititial lung diseases by traditional Chinese medicine].
    Tao K; Zhou XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Sep; 17(9):574-6. PubMed ID: 10322883
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of interstitial lung disease].
    Zsiray M
    Orv Hetil; 2004 Mar; 145(13):697-9. PubMed ID: 15125321
    [No Abstract]   [Full Text] [Related]  

  • 33. The acute (noninfectious) interstitial lung diseases.
    Schwarz MI
    Compr Ther; 1996 Oct; 22(10):622-30. PubMed ID: 8950078
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polyarteritis nodosa, cyclophosphamide and interstitial lung disease].
    Mera V
    Med Clin (Barc); 2000 Feb; 114(4):158. PubMed ID: 10734629
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia.
    Setoguchi Y; Ikeda T; Fukuchi Y
    Respirology; 2006 Jan; 11 Suppl():S41-5. PubMed ID: 16423270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
    Jain S; Shahane A; Derk CT
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic interstitial pneumonia: a clinicopathological perspective.
    Thannickal VJ
    Semin Respir Crit Care Med; 2006 Dec; 27(6):569-73. PubMed ID: 17195133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of fibrotic interstitial lung disease: current approaches and future directions.
    Johannson KA; Chaudhuri N; Adegunsoye A; Wolters PJ
    Lancet; 2021 Oct; 398(10309):1450-1460. PubMed ID: 34499866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To clot or not to clot, that is the question in pulmonary fibrosis.
    Strieter RM
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1589-90. PubMed ID: 12796052
    [No Abstract]   [Full Text] [Related]  

  • 40. [Merit and demerit of steroid therapy of interstitial lung disease].
    Kondo A
    Nihon Naika Gakkai Zasshi; 1994 May; 83(5):745-51. PubMed ID: 7964015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.